Abstract
Purpose: To assess the fertility preservation (FP) referral rates and patterns of newly diagnosed breast cancer in female adolescent and young adult (AYA) patients.Methods: Women aged 15–39 years with newly diagnosed breast cancer in Ontario from 2000 to 2017 were identified using the Ontario Cancer Registry. Exclusion criteria included prior sterilizing procedure, health insurance ineligibility, and prior infertility or cancer diagnosis. Women with a gynecology consult between cancer diagnosis and chemotherapy commencement with the billed infertility diagnostic code (ICD-9 628) were used as a surrogate for FP referral. The effect of age, parity, year of cancer diagnosis, staging, income, region, neighborhood marginalization, and rurality on referral status was investigated.Results: A total of 4452 patients aged 15–39 with newly diagnosed breast cancer met the inclusion criteria. Of these women, 178 (4.0%) were referred to a gynecologist with a billing code of infertility between cancer diagnosis and initiation of chemotherapy. Older patients, prior parity, and advanced disease were inversely correlated with referrals. Referral rates also varied regionally: patients treated in the south-east and south-west Local Health Integration Networks (LHINs) had the highest probability of referral, and patients covered by north LHINs had the lowest (central LHIN as reference). General surgeons accounted for 36.5% of all referrals, the highest percentage of all specialists. Referral rates significantly increased over time from 0.4% in 2000 to 10.7% in 2016.Conclusion: FP referral rates remain low and continue to be influenced by patient demographics and prognosis. These findings highlight the need for further interdisciplinary coordination in addressing the fertility concerns of AYA with newly diagnosed breast cancers.
Highlights
Breast cancer is the most commonly diagnosed malignancy among Canadian women of reproductive age.[1]
With the emergence of oncofertility, an interdisciplinary field aimed at addressing the reproductive needs of oncology patients, innovative technologies have been developed to provide fertility preservation (FP) treatments in patients undergoing gonadotoxic therapy
While the referral rates for fertility assessments in our study were remarkably low, they are consistent with prior findings
Summary
Breast cancer is the most commonly diagnosed malignancy among Canadian women of reproductive age.[1] Given advancements in therapeutic options, survival rates continue to improve,[2] and achieving a cure is no longer the sole goal. Efforts are directed toward addressing the physical and psychological impact of both the disease process as well as the associated treatment.[3] Fertility potential has a major impact on the quality of life of adolescent and young adult (AYA) cancer survivors.[4] With the emergence of oncofertility, an interdisciplinary field aimed at addressing the reproductive needs of oncology patients, innovative technologies have been developed to provide fertility preservation (FP) treatments in patients undergoing gonadotoxic therapy. Patient referral rates continue to be staggeringly low.[5,6,7,8,9]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
